128.99
-1.74 (-1.33%)
| Penutupan Terdahulu | 130.73 |
| Buka | 128.73 |
| Jumlah Dagangan | 141,649 |
| Purata Dagangan (3B) | 310,677 |
| Modal Pasaran | 3,174,689,024 |
| Harga / Pendapatan (P/E Ke hadapan) | 20.16 |
| Harga / Jualan (P/S) | 1.33 |
| Harga / Buku (P/B) | 1.63 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2025 - 11 Aug 2025 |
| Margin Keuntungan | -3.87% |
| Margin Operasi (TTM) | 4.89% |
| EPS Cair (TTM) | -3.83 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 6.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 80.57% |
| Nisbah Semasa (MRQ) | 2.59 |
| Aliran Tunai Operasi (OCF TTM) | 209.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 77.29 M |
| Pulangan Atas Aset (ROA TTM) | 1.79% |
| Pulangan Atas Ekuiti (ROE TTM) | -4.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menurun | Bercampur |
| Medical Instruments & Supplies (Global) | Menurun | Menurun | |
| Stok | ICU Medical, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | -0.13 |
|
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.04% |
| % Dimiliki oleh Institusi | 101.69% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 191.00 (Keybanc, 48.07%) | Beli |
| Median | 189.00 (46.52%) | |
| Rendah | 187.00 (Raymond James, 44.97%) | Beli |
| Purata | 189.00 (46.52%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 137.51 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Raymond James | 09 May 2025 | 187.00 (44.97%) | Beli | 138.30 |
| Keybanc | 21 Apr 2025 | 191.00 (48.07%) | Beli | 136.72 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 08 May 2025 | Pengumuman | ICU Medical Announces First Quarter 2025 Results |
| 01 May 2025 | Pengumuman | ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America |
| 24 Apr 2025 | Pengumuman | ICU Medical Announces Time of First Quarter 2025 Earnings Conference Call |
| 07 Apr 2025 | Pengumuman | ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps |
| 24 Mar 2025 | Pengumuman | ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |